Literature DB >> 12075488

Cerebral white matter involvement in children with mitochondrial encephalopathies.

I Moroni1, M Bugiani, A Bizzi, G Castelli, E Lamantea, G Uziel.   

Abstract

In childhood mitochondrial encephalopathies the common MRI features are bilateral symmetric abnormalities in basal nuclei and brainstem. The presence of diffuse white matter abnormality has been described only in a few cases. Among a series of 110 children with mitochondrial encephalopathies, 8 patients with MR imaging consistent with a leukoencephalopathy were retrospectively evaluated. Diagnosis was based on the recognition of the biochemical defect in muscle homogenate. H-MR spectroscopic imaging was performed in six of them. Biochemical analysis demonstrated a defect of respiratory chain complexes in six patients: complex I in two cases, complex II in two, complex IV in one, multiple complexes defect in one. Pyruvate dehydrogenase deficiency was demonstrated in two patients. MRI showed severe involvement of the brain white matter without significant basal nuclei or brainstem abnormalities. Two patients developed large cystic areas since onset; in two others progressive vacuolisation of affected white matter was seen later in the course of the disease. One patient with pyruvate dehydrogenase deficiency also presented with a diffuse cortical polymicrogyria. H-MR spectroscopic imaging showed a decrease of N-acetylaspartate, choline and creatine with lactate accumulation in five patients, and was normal in one. These findings suggest that mitochondrial disorders should be included in the differential diagnosis of white matter disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075488     DOI: 10.1055/s-2002-32372

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  13 in total

Review 1.  [Cerebral CT and MRI in mitchondrial disorders].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 2.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

Review 3.  Imaging of MELAS.

Authors:  Konark Malhotra; David S Liebeskind
Journal:  Curr Pain Headache Rep       Date:  2016-09

Review 4.  Therapies for mitochondrial diseases and current clinical trials.

Authors:  Ayman W El-Hattab; Ana Maria Zarante; Mohammed Almannai; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2017-09-18       Impact factor: 4.797

5.  Maternally inherited Leigh syndrome: an unusual cause of infantile apnea.

Authors:  Christy Shuk-kuen Chau; Ka-li Kwok; Daniel K Ng; Ching-Wan Lam; Sui-Fan Tong; Yan-Wo Chan; Wai-Kwan Siu; Yuet-Ping Yuen
Journal:  Sleep Breath       Date:  2009-08-11       Impact factor: 2.816

Review 6.  Advances in drug therapy for mitochondrial diseases.

Authors:  Lufei Zhang; Zhaoyong Zhang; Aisha Khan; Hui Zheng; Chao Yuan; Haishan Jiang
Journal:  Ann Transl Med       Date:  2020-01

Review 7.  Adult-onset leukodystrophies from respiratory chain disorders: do they exist?

Authors:  Ettore Salsano; Laura Farina; Costanza Lamperti; Giuseppe Piscosquito; Franco Salerno; Lucia Morandi; Franco Carrara; Eleonora Lamantea; Massimo Zeviani; Graziella Uziel; Mario Savoiardo; Davide Pareyson
Journal:  J Neurol       Date:  2013-01-29       Impact factor: 4.849

8.  Contribution of fetal MR imaging in the prenatal diagnosis of Zellweger syndrome.

Authors:  F Mochel; A-G Grébille; A Benachi; J Martinovic; F Razavi; D Rabier; I Simon; N Boddaert; F Brunelle; P Sonigo
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

Review 9.  Neuroimaging of mitochondrial disease.

Authors:  Russell P Saneto; Seth D Friedman; Dennis W W Shaw
Journal:  Mitochondrion       Date:  2008-05-23       Impact factor: 4.160

10.  A modern approach to the treatment of mitochondrial disease.

Authors:  Sumit Parikh; Russell Saneto; Marni J Falk; Irina Anselm; Bruce H Cohen; Richard Haas; The Mitochondrial Medicine Society
Journal:  Curr Treat Options Neurol       Date:  2009-11       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.